Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) FCF Margin (2016 - 2025)

Biomerica's FCF Margin history spans 16 years, with the latest figure at 81.9% for Q4 2025.

  • For Q4 2025, FCF Margin fell 3355.0% year-over-year to 81.9%; the TTM value through Nov 2025 reached 66.52%, up 2322.0%, while the annual FY2025 figure was 72.32%, 2762.0% up from the prior year.
  • FCF Margin for Q4 2025 was 81.9% at Biomerica, down from 19.42% in the prior quarter.
  • Across five years, FCF Margin topped out at 30.6% in Q1 2022 and bottomed at 177.09% in Q1 2024.
  • The 5-year median for FCF Margin is 82.68% (2025), against an average of 70.45%.
  • The largest annual shift saw FCF Margin surged 14867bps in 2021 before it tumbled -18640bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 28.62% in 2021, then tumbled by -392bps to 83.47% in 2022, then surged by 35bps to 54.12% in 2023, then grew by 11bps to 48.35% in 2024, then plummeted by -69bps to 81.9% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's FCF Margin are 81.9% (Q4 2025), 19.42% (Q3 2025), and 88.25% (Q2 2025).